California firm takes cannabinoid research personally

by Invesbrain Tuesday, July 18, 2017
Print This Article

California firm looks to Israel for personalized cannabinoid approach

The news magazine ISRAEL21c reports a U.S. biopharma company is teaming up with an Israeli counterpart to forward the use of cannabinoids in the field of personalized medicine.

California-based CURE Pharmaceutical recently signed a memorandum of understanding with Therapix Biosciences of Tel Aviv. The “research collaboration” will be done in conjunction with the eight hospitals and medical centres of Israel’s Assuta Medical Centers.

Therapix’s lead compound THX-TS01 is currently in phase 2 clinical trials to treat Tourette’s syndrome. It hopes to begin a Phase 1 clinical trial for another compound, THX-ULD01, for the treatment of mild cognitive impairment.

Both compounds employ an “FDA-approved synthetic THC.”

Therapix is also developing new cannabinoid delivery technologies including nasal and sublingual (under the tongue) methods.


CMAJ commentary argues for two-stream cannabis system

Arguing ‘recreational cannabis and cannabinoid-based drugs (including medical cannabis) are not equivalent,’ the authors of a commentary in the Canadian Medical Association Journal say Canada should continue with a separate medical cannabis stream after legalization.

In a report by EurekAlert!, Elizabeth Cairns and Dr. Melanie Kelly of Dalhousie University’s Department of Pharmacology, write that “(without) a program that supports medical use, patients may lose access to treatments that the Federal Court of Canada has deemed appropriate, which fosters safe and appropriate use."

The Task Force on Cannabis Legalization and Regulation also recommended a two-streamed system.
According to the EurekAlert! report, “the authors suggest that a medical stream for cannabis and cannabinoids would reduce risk to patients, provide incentives for research into the therapeutic effects of cannabinoids, and provide educational resources for health care practitioners on the latest advances in cannabinoid research.”


U.S.-German-Israeli deal links cancer diagnostics with cannabinoids

MMJ Reporter writes an American cannabinoid firm with an R&D foothold in Israel is teaming up with a German “world pioneer in cancer diagnostics.”

Cannabics Pharmaceuticals Inc. recently agreed to become “the exclusive international provider unit” of SIMFO GmbH’s Circulating Tumour Cell (CTC) diagnostics to people suffering with cancer and being treated with CBDs.

SIMFO previously initiated preclinical trials into CBDs and drug development with Cannabics’ cannabinoid formulations.

Cannabics’ R&D facility is “concentrated” in Israel.


Data on CBD analogue to be presented at neuroscience meeting

Stockhouse reports Califonia-based NEMUS Bioscience is set to present research on its CBD analogue at the Annual Meeting of the Society of Neuroscience this November.

The data, compiled by NEMUS’ R&D partner the University of Mississippi “will show the superiority of the NEMUS proprietary analogue of CBD, NB2222, versus plant-derived CBD in ameliorating pain in a validated mouse (murine) model of chemotherapy-induced peripheral neuropathy using an opioid as an active comparator.”

The firm will also present data on the anti-addictive potential of NB2222.

"We have been able to demonstrate that NB2222 was able to deliver analgesia comparable to morphine, which has been implicated in the current global opioid abuse epidemic. The research team then moved to the next step using a validated animal model of addiction to opioids to assess the anti-abuse potential of NB2222 as a therapeutic. We look forward to presenting the data this fall," said Dr. Kenneth Sufka, research professor with the National Center for Natural Products Research at UM.


The Only Good Cigar is a Cannagar

Nobody actually enjoys cigars. I am convinced of this. Most people agree with me. Things that are actually enjoyable (and not some bizarre “masculine” ritual) tend to be popular. Cigars are not: more than ninety-five percent of American adults do not smoke cigars, according...

Cannabis World Congress and Business Expo LA Event Preview

The legal cannabis industry is booming, bringing a wave of entrepreneurs, businesses, growers and legislators looking to network, expand their own businesses and keep up with an ever-increasing legal cannabis industry landscape. That’s where Cannabis Week comes in. Anchored b...

Shambhala 2019 with Kass and Honey

Feel the Shambalove as Kass and Honey check out the Shambhala Music Festival for the first time and get “welcomed home” by their new “family”. On August 9-12, we sent correspondents Kass and Honey to Shambhala, one of Canada’s longest-running electronic festivals, at t...

$42 million loss in latest fiscal year – Ontario’s pot Crown corporation

TORONTO — Ontario Cannabis Retail Corp. lost $42 million in the latest fiscal year, according to newly released public documents. The provincial Crown corporation tasked with online sales and wholesale distribution of recreational pot reported revenues of $64 million fo...

The Fight for Automatic Criminal Record Expungement in the Midwest

The conversation around expunging the records of petty offenders is now a keystone of any real conversation on reforming marijuana laws. In Michigan, a few lawmakers have figured this out, following in the footsteps of their neighbors to the southwest in Illinois. On Tuesday, Se...

Valens GroWorks stock is very undervalued, GMP says

The pipeline of opportunities is plentiful for cannabis extraction company Valens GroWorks (Valens GroWorks Stock Quote, Chart, News TSXV:VGW), says GMP Securities analyst Ryan Macdonell, who in a Thursday note to clients reported on the company’s just-announced white label be...

Rising Tide Consultants founder launches new Liquor and Cannabis Podcast, License to Chill

For over 30 years, licensing expert Bert Hick has been at the forefront of business development and regulation compliance. Now, the Rising Tide Consultants founder brings that wealth of industry knowledge and experience to the table, starting a new and exciting journey, tackling...

Hemp Makes Marijuana Crimes Difficult to Prosecute

While Senate Majority Leader Mitch McConnell would like to think that, in addition to being the “Grim Reaper” of Capitol Hill, he hung the moon and is perhaps even the savior of American morality, it turns out that he’s probably not as smart as he’d like to believe. Beca...

Trulieve Cannabis is king in the state of Florida, says GMP Securities

Bullish data from Florida is cause for a forecast revision for Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News CSE:TRUL), says Robert Fagan, analyst for GMP Securities, who in a note to clients on Thursday reiterated his “Buy” rating and C$30.00 target, which r...

Dutchie, a Leading Online Cannabis Marketplace, Secures $15 Million

BEND, Ore., Sept. 11, 2019 /PRNewswire/ -- Dutchie, the leading e-commerce platform for cannabis pickup and delivery, closed a $15 million Series A round supported by a powerhouse group of investors, including: The post Dutchie, a Leading Online Cannabis Marketplace, Secures $15...